| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
30,639 |
24,955 |
$1.38M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,873 |
3,136 |
$172K |
| T1015 |
Clinic visit/encounter, all-inclusive |
18,492 |
15,811 |
$145K |
| 90837 |
Psychotherapy, 53 minutes with patient |
1,422 |
842 |
$69K |
| 90834 |
Psychotherapy, 45 minutes with patient |
667 |
546 |
$36K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
1,688 |
996 |
$29K |
| 90832 |
Psychotherapy, 30 minutes with patient |
587 |
421 |
$24K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
392 |
282 |
$21K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
270 |
174 |
$14K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,413 |
2,335 |
$10K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
447 |
373 |
$9K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
228 |
212 |
$9K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
143 |
104 |
$7K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,330 |
904 |
$6K |
| 90686 |
|
1,226 |
906 |
$6K |
| 90670 |
|
72 |
51 |
$3K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
49 |
38 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
161 |
139 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
266 |
236 |
$2K |
| 90651 |
|
47 |
25 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
192 |
158 |
$921.02 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
56 |
51 |
$326.71 |
| 90648 |
|
152 |
100 |
$221.13 |
| 90633 |
|
92 |
64 |
$198.57 |
| G0009 |
Administration of pneumococcal vaccine |
73 |
39 |
$162.73 |
| 90723 |
|
57 |
39 |
$156.03 |
| 81002 |
|
198 |
130 |
$28.19 |
| 86318 |
|
33 |
29 |
$18.90 |
| 36415 |
Collection of venous blood by venipuncture |
174 |
139 |
$9.18 |
| 90461 |
|
14 |
12 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
17 |
17 |
$0.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
18 |
16 |
$0.00 |